Register

Site

AIDS Treatment Data Network

Content

The Directory of Clinical Trials describes currently enrolling trials of treatments for HIV infection, HIV-related symptoms and conditions (such as anemia, neutropenia, diarrhea, fatigue,etc.) and opportunistic infections and cancers. The trials are sub-divided into ‘trials of drugs to treat:

  • HIV (46 trials)
  • Opportunistic infections (further sub-divided into 47 categories of infection/drug being studied)
  • Children (18 trials)
  • Pregnant women (4)
  • Preventive and therapeutic vaccine trials (5), andInformation gathering studies, including both quantitative and qualitative research protocols (12).’

The AIDS Treatment Data Network is a national, not-for-profit, community-based organization, that provides English and Spanish language case management, treatment information, counseling, advocacy and support services for men, women and children with HIV.

Other information available

Also on the clinical trials page are details of expanded access and compassionate use programs, patient assistant programs and PHS guidelines for prevention of opportunistic infections. The remainder of the site includes English or Spanish language fact sheets, glossaries, treatment bulletins, details of alternative treatments, and news. There are links to sites for various HIV/AIDS research groups and projects.

Access

Free. No password or pre-registration required. Donations.

Comments

The Trials Directory is updated on an ongoing basis, as studies open and close. Academic, community and industry investigators are contacted once a month for trials taking place in New York State, New Jersey, Connecticut, Philadelphia,PA and Bethesda,MD (The NCI, The NIH, and The NIAID). The majority of the trials will also be found on the ACTIS database, but a few smaller, local investigator-initiated studies will appear only in this Directory.
There is a basic keyword search facility for the whole site. Some sections of the Clinical Trials page are said to have been modified in January 2000.

Register

Site

AIDS Treatment Data Network

Content

The Directory of Clinical Trials describes currently enrolling trials of treatments for HIV infection, HIV-related symptoms and conditions (such as anemia, neutropenia, diarrhea, fatigue,etc.) and opportunistic infections and cancers. The trials are sub-divided into ‘trials of drugs to treat:

  • HIV (46 trials)
  • Opportunistic infections (further sub-divided into 47 categories of infection/drug being studied)
  • Children (18 trials)
  • Pregnant women (4)
  • Preventive and therapeutic vaccine trials (5), andInformation gathering studies, including both quantitative and qualitative research protocols (12).’

The AIDS Treatment Data Network is a national, not-for-profit, community-based organization, that provides English and Spanish language case management, treatment information, counseling, advocacy and support services for men, women and children with HIV.

Other information available

Also on the clinical trials page are details of expanded access and compassionate use programs, patient assistant programs and PHS guidelines for prevention of opportunistic infections. The remainder of the site includes English or Spanish language fact sheets, glossaries, treatment bulletins, details of alternative treatments, and news. There are links to sites for various HIV/AIDS research groups and projects.

Access

Free. No password or pre-registration required. Donations.

Comments

The Trials Directory is updated on an ongoing basis, as studies open and close. Academic, community and industry investigators are contacted once a month for trials taking place in New York State, New Jersey, Connecticut, Philadelphia,PA and Bethesda,MD (The NCI, The NIH, and The NIAID). The majority of the trials will also be found on the ACTIS database, but a few smaller, local investigator-initiated studies will appear only in this Directory.There is a basic keyword search facility for the whole site. Some sections of the Clinical Trials page are said to have been modified in January 2000.